细胞毒性T细胞
免疫系统
三阴性乳腺癌
癌症研究
免疫疗法
肿瘤微环境
CD8型
T细胞
医学
免疫学
乳腺癌
紫杉醇
树突状细胞
癌症免疫疗法
抗原
免疫原性细胞死亡
癌症
抗原呈递
细胞
癌细胞
生物
肿瘤抗原
抗原提呈细胞
PD-L1
作者
Daiqin Luo,Xianhuai Jin,Shuai Zhang,Xianlin Zeng,Shuling Zhang,Daohong Li,Wei Xiong,Yan Luo,Zuquan Hu,Jinhua Long,Zhu Zeng
标识
DOI:10.3389/fimmu.2026.1765165
摘要
Background Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by high metastatic potential and resistance to conventional therapies, representing a significant clinical challenge. Although nano albumin-bound paclitaxel (nab-PTX) has demonstrated generally good treatment effect, the mechanisms underlying its enhanced therapeutic performance, particularly its potential immunomodulatory effects, remain unclear. Methods Using both in vitro and in vivo TNBC models, we investigated the immunomodulatory effects of nab-PTX. Specifically, we evaluated its ability to induce immunogenic cell death (ICD), activate dendritic cells (DCs) via the cGAS-STING signaling pathway, and influence CD8 + T cell recruitment and infiltration within the tumor microenvironment. Results Treatment with nab-PTX induced ICD in TNBC cells was associated with enhanced activation of DCs through the cGAS-STING pathway. This activation was accompanied by improved antigen presentation and a significant increase in intratumoral CD8 + T cell infiltration. Collectively, these immune alterations suggest that nab-PTX contributes to a more immunologically active tumor microenvironment, characterized by heightened T cell mediated immune engagement. Conclusion Our study indicate that, beyond its direct cytotoxic effects, nab-PTX may exert anti-tumor activity in TNBC through modulation of the tumor immune microenvironment. By inducing ICD and promoting DCs activation, nab-PTX appears to support CD8 + T cell recruitment, thereby potentially enhancing immune mediated tumor regression. This immunologically supportive role of nab-PTX highlights its potential value in strategies aimed at improving the efficacy of chemotherapy based or immunotherapy combined treatments in TNBC.
科研通智能强力驱动
Strongly Powered by AbleSci AI